State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019 - Role of intra-Clonal HEterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias Accéder directement au contenu
Article Dans Une Revue Journal for Immunotherapy of Cancer Année : 2019

Dates et versions

hal-02299391 , version 1 (27-09-2019)

Identifiants

Citer

Richard Lemal, Olivier Tournilhac. State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019. Journal for Immunotherapy of Cancer, 2019, 7 (1), pp.202. ⟨10.1186/s40425-019-0686-x⟩. ⟨hal-02299391⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More